The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a cfDNA-based protein-informed epigenetic signature (PEp-sig) to enable biomarker-based risk stratification for pancreatic ductal adenocarcinoma (PDA).
 
Ashish Manne
Honoraria - Onclive
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Cardinal Health
 
Lianbo Yu
No Relationships to Disclose
 
Adam Khorasanchi
No Relationships to Disclose
 
Timothy Pawlik
No Relationships to Disclose
 
Jordan Cloyd
Other Relationship - Journal of Gastrointestinal Cancer
 
Ravi Paluri
Honoraria - Exelixis; Ipsen; Seagen
Consulting or Advisory Role - Exelixis; Ipsen
Speakers' Bureau - Exelixis; Ipsen
Research Funding - Geistlich Pharma; Minneamrita Therapeutics; Seagen
 
Kannan Thanikachalam
No Relationships to Disclose
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Ashwini Esnakula
No Relationships to Disclose
 
Anne Noonan
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I); DAVA Pharmaceuticals; Deciphera (I); Eisai; Elevar Therapeutics; Exelixis; GOG Foundation (I); Helsinn Healthcare; Immunogen (I); Merck (I); OncLive/MJH Life Sciences; OncLive/MJH Life Sciences (I); QED Therapeutics; Taiho Pharmaceutical
 
Arjun Mittra
Stock and Other Ownership Interests - Lilly
Research Funding - Tempus (Inst); THERIVA BIOLOGICS, SL. (Inst)
 
Ning Jin
No Relationships to Disclose
 
Shafia Rahman
No Relationships to Disclose
 
John Hays
Consulting or Advisory Role - AADi; Alkermes; AstraZeneca; Clovis Oncology; Deciphera; Immunogen; Ipsen; Merck; Mersana; Mural Oncology; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Merck; Regeneron; Tesaro
 
Susan Tsai
No Relationships to Disclose
 
Sravan Jeepalyam
No Relationships to Disclose
 
Deepak Sherpally
No Relationships to Disclose
 
Wancai Yang
No Relationships to Disclose